Demonstration Study: A Protocol to Combine Online Tools and Databases for Identifying Potentially Repurposable Drugs

Traditional methods for discovery and development of new drugs can be very time-consuming and expensive processes because they include several stages, such as compound identification, pre-clinical and clinical trials before the drug is approved by the U.S. Food and Drug Administration (FDA). Therefore, drug repurposing, namely using currently FDA-approved drugs as therapeutics for other diseases than what they are originally prescribed for, is emerging to be a faster and more cost-effective alternative to current drug discovery methods. In this paper, we have described a three-step in silico protocol for analyzing transcriptomics data using online databases and bioinformatics tools for identifying potentially repurposable drugs. The efficacy of this protocol was evaluated by comparing its predictions with the findings of two case studies of recently reported repurposed drugs: HIV treating drug zidovudine for the treatment of dry age-related macular degeneration and the antidepressant imipramine for small-cell lung carcinoma. The proposed protocol successfully identified the published findings, thus demonstrating the efficacy of this method. In addition, it also yielded several novel predictions that have not yet been published, including the finding that imipramine could potentially treat Severe Acute Respiratory Syndrome (SARS), a disease that currently does not have any treatment or vaccine. Since this in silico protocol is simple to use and does not require advanced computer skills, we believe any motivated participant with access to these databases and tools would be able to apply it to large datasets to identify other potentially repurposable drugs in the future.

[1]  M. Ronaghi,et al.  Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data , 2010, PloS one.

[2]  Pierre R. Bushel,et al.  CEBS—Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data , 2007, Nucleic Acids Res..

[3]  M. Wabl,et al.  An autoimmune disease prevented by anti-retroviral drugs , 2011, Retrovirology.

[4]  A. Morris,et al.  Metformin in cancer treatment and prevention. , 2015, Annual review of medicine.

[5]  C. Chong,et al.  New uses for old drugs , 2007, Nature.

[6]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[7]  Alexander A. Morgan,et al.  Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.

[8]  Aaron M. Newman,et al.  Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks , 2012, Genome Medicine.

[9]  Takeshi Mizutani,et al.  Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity , 2014, Science.

[10]  M. Fielden,et al.  The liver pharmacological and xenobiotic gene response repertoire , 2008, Molecular systems biology.

[11]  J. Sugar,et al.  Imipramine inhibiton of ragweed allergic conjunctivitis. , 1984, Investigative ophthalmology & visual science.

[12]  L. Frenzel,et al.  Therapeutic Options for Adult T-Cell Leukemia/Lymphoma , 2013, Current Oncology Reports.

[13]  H. Yamada,et al.  The Japanese toxicogenomics project: application of toxicogenomics. , 2010, Molecular nutrition & food research.

[14]  A. Butte,et al.  A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. , 2013, Cancer discovery.

[15]  J. Arbiser,et al.  Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis , 2016, Clinical Cancer Research.

[16]  Lu Lu,et al.  Development of SARS vaccines and therapeutics is still needed , 2012, Future virology.

[17]  D. Borsook,et al.  The Effect of Antinociceptive Drugs Tested at Different Times After Nerve Injury in Rats , 2005, Anesthesia and analgesia.

[18]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[19]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[20]  P. Sanseau,et al.  Computational Drug Repositioning: From Data to Therapeutics , 2013, Clinical pharmacology and therapeutics.

[21]  H. Ghofrani,et al.  Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond , 2006, Nature Reviews Drug Discovery.

[22]  M. Ostrowski,et al.  Distinct Transcriptional Profiles in Ex Vivo CD4+ and CD8+ T Cells Are Established Early in Human Immunodeficiency Virus Type 1 Infection and Are Characterized by a Chronic Interferon Response as Well as Extensive Transcriptional Changes in CD8+ T Cells , 2007, Journal of Virology.

[23]  D. Swinney,et al.  How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.